To evaluate whether the expression of the biomarkers Phospho-Rb S249, N-cadherin, β-catenin, and E-cadherin could identify patients at risk of developing an aggressive PCa, a classification tree was constructed (Figure 2). The gene discussed is CDH2; the disease is posterior cortical atrophy.